The ability of RS1 and RS2 to inhibit the growth of cancer cell lines was also assessed, revealing that RS1 exhibited moderate cytotoxicity when used to treat the CT26.WT and HT-29 cell lines, with respective IC50 values of 47.44 and 64.81 ug/mL. Here, DDX53 is linked to cancer.